• Profile
Close

Clinical utility of antigen carbohydrate 125 for planning the optimal length of stay in acute heart failure

European Journal of Internal Medicine Jun 16, 2021

Lorenzo M, Palau P, Llacer P, et al. - This study was undertaken to investigate if there is a differential impact of length of stay (LOS) on the risk of 6-month acute heart failure (AHF) readmission across carbohydrate 125 (CA125) levels. Researchers designed a retrospective study including a total of 1,387 patients discharged for AHF in two third-level centers. CA125 was measured 48±24 h after admission. They examined the relationship between CA125 and LOS with the risk of subsequent AHF readmission at 6 months by Cox regression analysis accounting for death as a competing event. The results showed that high CA125 levels may identify those patients that benefit from a more prolonged hospitalization in terms of reducing the risk of mid-term AHF readmissions in patients with AHF.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay